Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 198.69

+2.0%

Dec 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Flagrante Delictu who wrote (13517)	1/20/1998 11:51:00 AM
From: Andrew H	Read Replies (5) of 32384

Hey Bernie, welcome back from H and Q and to SI. >>At the breakout session after the LGND presentation at H&Q, Dr. Steven Reich seemed to indicate that LGND would be going forward in the areas of NSCLC, prostate, ovarian, & breast cancer.<< That sounds like unexpectedly good news. With the prostate, ovarian and breast cancers, do you know if we are talking Targretin or Panretin? Also will you be putting together a complete report on the presentation and breakout for the thread?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next